Balance sheet of Oxygenta Pharma is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of Oxygenta Pharma is increasing.
Latest net debt of Oxygenta Pharma is ₹62.11 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹57.03 Crs.

The profit is oscillating.
The profit of Oxygenta Pharma is -₹10.3 Crs for TTM, -₹3.48 Crs for Mar 2024 and -₹11.57 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Oxygenta Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory